Lemon Tree Hotels Q2 Results: Net profit surges 64% to ₹57 crore, revenue up 18%
Lemon Tree Hotels reported a 63.7 percent increase in consolidated net profit to Rs 56.6 crore for Q2 FY27, while revenue rose 18 percent to Rs 361.4 crore.

Lemon Tree Hotels on Thursday, November 5 reported a 63.7% year-on-year increase in consolidated net profit to ₹56.6 crore for the second quarter of FY27, compared with ₹34.6 crore in the corresponding quarter last year.Revenue from operations increased 18% to ₹361.4 crore in Q2 FY27 from ₹306.3 crore a year earlier. Earnings before interest, tax, depreciation and amortisation rose 22.2% to ₹159.7 crore from ₹130.7 crore in the year-ago quarter.The company's EBITDA margin improved to 44.2% in the reporting quarter from 42.7% in Q2 FY26, indicating an improvement in operating profitability.Executive Chairman Patanjali Keswani highlighted the company's growth in revenue and profitability, along with the improvement in EBITDA margin. His comments focused on the company's operating performance and business momentum during the September quarter.Lemon Tree Hotels Q1 performanceIn the June quarter, Lemon Tree Hotels reported a 20.1% year-on-year increase in consolidated net profit attributable to equity holders of the parent to ₹46 crore, compared with ₹38.3 crore in the corresponding quarter last year.
Revenue from operations rose 9.1% year-on-year to ₹344.6 crore in Q1 FY27 from ₹315.8 crore a year earlier.Lemon Tree Hotels shares closed at ₹117.55 on the BSE, up ₹2 during the session. The stock opened at ₹117.25. It has a 52-week high of ₹168 and a 52-week low of ₹99.70.Lemon Tree Hotels Limited operates across the upscale, upper-midscale, midscale and economy segments of the hospitality industry. The company owns, leases, operates and franchises hotels under brands including Aurika Hotels & Resorts, Lemon Tree Premier, Lemon Tree Hotels, Red Fox Hotels, Keys Prima, Keys Select and Keys Lite.
Related Stories

Laurus Labs, Gland Pharma, Piramal, Divi's Labs: 4 drug manufacturing stocks rally up to 89% in 6 months - Upside ahead?
Pharma stocks, particularly CDMO companies, have surged over the past six months amid optimism about quarterly results. Laurus Labs led with an 88.64% gain, followed by Gland Pharma at 80.36%, Divi’s Laboratories at 72.35% and Piramal Pharma at 38.65%.

NMDC Steel Q2 Results: Firm swings to black, posts ₹61 crore profit; margin expands
NMDC Steel returned to profitability in Q2 FY27, reporting a net profit of ₹61 crore against a loss of ₹115 crore a year ago. Revenue increased 11%, while EBITDA rose to ₹462.2 crore and the margin expanded to 12.3%.

Oil India dividend, Q2 results 2026: PSU giant announces interim payout as profit more than doubles - Check record date
Oil India’s standalone Q2 FY27 net profit more than doubled year over year to ₹2,259.42 crore, while revenue rose to ₹8,071.33 crore. The board approved an interim dividend of ₹7 per share, with November 20 as the record date.
